US FDA approves cancer therapy by Johnson & Johnson and Legend Biotech
The treatment, Carvykti/Cilta-cel, belongs to a class of drugs known as CAR-T therapies, or chimeric antigen receptor T-cell…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.